Rapport Therapeutics, Inc.
RAPP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002012593
In the last 90 days, Rapport Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Rapport Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 124 | 144 | +20 |
| Shares | 49.3M | 51.1M | +1.81M (+3.7%) |
| Value | $1.46B | $1.55B | +$86.4M (+5.9%) |
New holders (40)
Institutions that held Rapport Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (20)
Institutions that held Rapport Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Franklin Resources Inc | 250,590 | $7.44M |
| Sphera Funds Management Ltd. | 157,533 | $4.68M |
| Fort Baker Capital Management LP | 81,644 | $2.42M |
| Soleus Capital Management, L.P. | 80,000 | $2.38M |
| MPM Oncology Impact Management LP | 71,807 | $2.13M |
| Walleye Capital LLC | 69,570 | $2.07M |
| Schonfeld Strategic Advisors LLC | 57,148 | $1.70M |
| Jane Street Group, LLC | 46,223 | $1.37M |
| Freestone Grove Partners LP | 45,130 | $1.34M |
| Boothbay Fund Management, LLC | 28,972 | $860.5K |
| Maven Securities LTD | 20,000 | $594.0K |
| Tudor Investment Corp Et Al | 11,149 | $331.1K |
| SummitTX Capital, L.P. | 9,830 | $292.0K |
| State of Tennessee, Treasury Department | 5,400 | $160.4K |
| Caption Management, LLC | 5,000 | $148.5K |
| Bryn Mawr Trust Co | 4,822 | $143.2K |
| Belvedere Trading LLC | 3,728 | $110.7K |
| Group One Trading, L.P. | 2,475 | $73.5K |
| Rise Advisors, LLC | 50 | $1.49K |
| Clearstead Advisors, LLC | 33 | $981 |